PMID:11705991: Difference between revisions

From EcoliWiki
Jump to navigation Jump to search
Edited by wikibot
Edited by wikibot
Line 1: Line 1:
{{RightTOC}}
{{RightTOC}}


Line 30: Line 29:
!Gene product!!Qualifier!!GO ID!!GO term name!!Evidence Code!!with/from!!Aspect!!Notes!!Status
!Gene product!!Qualifier!!GO ID!!GO term name!!Evidence Code!!with/from!!Aspect!!Notes!!Status
|-class='sortbottom'
|-class='sortbottom'
|[{{SERVER}}/colipedia/index.php?title=Special:TableEdit&id=63ce1649aab8b3180235b0af7618f667.0.U47a96f590ebf5&page=0&pagename={{FULLPAGENAMEE}} edit table] || || || || || || || ||
|[{{SERVER}}{{SCRIPTPATH}}/index.php?title=Special:TableEdit&id=63ce1649aab8b3180235b0af7618f667.0.U47a96f590ebf5&page=0&pagename={{FULLPAGENAMEE}} edit table] || || || || || || || ||
|}
|}
<!--box uid=63ce1649aab8b3180235b0af7618f667.0.U47a96f590ebf5-->
<!--box uid=63ce1649aab8b3180235b0af7618f667.0.U47a96f590ebf5-->

Revision as of 12:29, 30 April 2008

Zdraveski, ZZ, Mello, JA, Farinelli, CK, Essigmann, JM and Marinus, MG (2002) MutS preferentially recognizes cisplatin- over oxaliplatin-modified DNA.J. Biol. Chem. 277:1255-60

Abstract Loss of mismatch repair leads to tumor resistance by desensitizing cells to specific DNA-damaging agents, including the anticancer drug cisplatin. Cisplatin analogs with a diamminocyclohexane (DACH) carrier ligand, such as oxaliplatin and Pt(DACH)Cl(2), do not elicit resistance in mismatch repair-deficient cells and therefore present promising therapeutic agents. This study compared the interactions of the purified Escherichia coli mismatch repair protein MutS with DNA modified to contain cisplatin and DACH adducts. MutS recognized the cisplatin-modified DNA with 2-fold higher affinity in comparison to the DACH-modified DNA. ADP stimulated the binding of MutS to cisplatin-modified DNA, whereas it had no effect on the MutS interaction with DNA modified by DACH or EN adducts. In parallel cytotoxicity experiments, methylation-deficient E. coli dam mutants were 2-fold more sensitive to cisplatin than DACH compounds. A panel of recombination-deficient mutants showed striking sensitivity to both compounds, indicating that both types of adducts are strong replication blocks. The differential affinity of MutS for DNA modified with the different platinum analogs could provide the molecular basis for the distinctive cellular responses to cisplatin and oxaliplatin.
Links PubMed

Significance

You can help EcoliWiki by summarizing why this paper is useful

Useful Materials and Methods

You can help Ecoliwiki by describing the useful materials (strains, plasmids, antibodies, etc) described in this paper.

Annotations

Gene product Qualifier GO ID GO term name Evidence Code with/from Aspect Notes Status
edit table

EcoliWiki Links

Add links to pages that link here (e.g. gene, product, method pages)

References

See Help:References for how to manage references in EcoliWiki.